Ubs Group Ag Bei Gene, Ltd. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 35,724 shares of BGNE stock, worth $6.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,724

Previous 12,086 195.58%

Holding current value

$6.35 Million

Previous $1.72 Million 365.2%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$143.93 - $224.51 $3.4 Million - $5.31 Million	23,638 Added 195.58%	35,724 $8.02 Million
Q2 2024 Aug 13, 2024	SELL	$129.52 - $174.32 $2.14 Million - $2.89 Million	-16,561 Reduced 57.81%	12,086 $1.72 Million
Q1 2024 May 13, 2024	BUY	$141.8 - $181.47 $3 Million - $3.84 Million	21,136 Added 281.4%	28,647 $4.48 Million
Q4 2023 Feb 09, 2024	SELL	$158.67 - $201.58 $3.14 Million - $3.99 Million	-19,786 Reduced 72.48%	7,511 $1.35 Million
Q3 2023 Nov 09, 2023	SELL	$179.87 - $225.13 $11.3 Million - $14.2 Million	-62,877 Reduced 69.73%	27,297 $4.91 Million
Q2 2023 Aug 11, 2023	BUY	$178.3 - $266.78 $9.63 Million - $14.4 Million	54,016 Added 149.39%	90,174 $16.1 Million
Q1 2023 May 12, 2023	BUY	$215.53 - $274.5 $6.52 Million - $8.3 Million	30,234 Added 510.36%	36,158 $7.79 Million
Q4 2022 Feb 08, 2023	SELL	$125.51 - $229.3 $5.83 Million - $10.7 Million	-46,450 Reduced 88.69%	5,924 $1.3 Million
Q3 2022 Nov 10, 2022	BUY	$131.8 - $202.24 $4.61 Million - $7.08 Million	35,007 Added 201.57%	52,374 $7.06 Million
Q2 2022 Aug 10, 2022	SELL	$121.11 - $216.05 $8.14 Million - $14.5 Million	-67,205 Reduced 79.46%	17,367 $2.81 Million
Q1 2022 May 16, 2022	BUY	$146.52 - $269.56 $5.88 Million - $10.8 Million	40,148 Added 90.37%	84,572 $16 Million
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $10.5 Million - $16.4 Million	-42,154 Reduced 48.69%	44,424 $12 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $9.19 Million - $14.9 Million	36,837 Added 74.06%	86,578 $31.4 Million
Q2 2021 Aug 13, 2021	BUY	$292.75 - $367.01 $895,815 - $1.12 Million	3,060 Added 6.56%	49,741 $17.1 Million
Q1 2021 May 12, 2021	SELL	$260.64 - $382.12 $10.5 Million - $15.4 Million	-40,175 Reduced 46.25%	46,681 $16.2 Million
Q4 2020 Feb 11, 2021	BUY	$221.31 - $316.61 $13.3 Million - $19 Million	60,059 Added 224.13%	86,856 $22.4 Million
Q3 2020 Nov 12, 2020	SELL	$189.18 - $286.44 $3.03 Million - $4.58 Million	-16,003 Reduced 37.39%	26,797 $7.68 Million
Q2 2020 Jul 31, 2020	BUY	$123.9 - $195.41 $79,048 - $124,671	638 Added 1.51%	42,800 $8.06 Million
Q1 2020 May 01, 2020	BUY	$121.84 - $173.19 $2.79 Million - $3.97 Million	22,913 Added 119.03%	42,162 $5.19 Million
Q4 2019 Feb 14, 2020	SELL	$115.78 - $208.34 $1.14 Million - $2.06 Million	-9,880 Reduced 33.92%	19,249 $3.19 Million
Q3 2019 Nov 14, 2019	SELL	$120.61 - $148.29 $5.41 Million - $6.65 Million	-44,852 Reduced 60.63%	29,129 $3.57 Million
Q2 2019 Aug 14, 2019	SELL	$113.99 - $146.86 $2.02 Million - $2.6 Million	-17,686 Reduced 19.29%	73,981 $9.17 Million
Q1 2019 May 14, 2019	BUY	$122.82 - $151.83 $3.09 Million - $3.83 Million	25,195 Added 37.9%	91,667 $12.1 Million
Q4 2018 Feb 14, 2019	SELL	$107.01 - $175.15 $7.38 Million - $12.1 Million	-68,990 Reduced 50.93%	66,472 $9.32 Million
Q3 2018 Nov 14, 2018	BUY	$152.62 - $189.66 $7.01 Million - $8.71 Million	45,942 Added 51.32%	135,462 $23.3 Million
Q2 2018 Aug 14, 2018	BUY	$152.5 - $216.77 $2.07 Million - $2.94 Million	13,550 Added 17.84%	89,520 $13.8 Million
Q1 2018 May 15, 2018	SELL	$97.41 - $177.22 $410,777 - $747,336	-4,217 Reduced 5.26%	75,970 $12.8 Million
Q4 2017 Feb 14, 2018	BUY	$79.6 - $114.73 $2.75 Million - $3.96 Million	34,491 Added 75.48%	80,187 $7.84 Million
Q3 2017 Nov 14, 2017	BUY	$66.19 - $103.46 $2.63 Million - $4.12 Million	39,782 Added 672.68%	45,696 $4.73 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,919 Added 196.44%	5,914 $266,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,995	1,995 $73,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.4B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account